Literature DB >> 25821197

Low-density lipoprotein apheresis for corticosteroid-resistant skin lesions caused by cholesterol crystal embolism: a case report and review of the literature.

Hiroki Kobayashi1, Masanori Abe, Yusuke Murata, Takashi Maruyama, Tetsuya Furukawa, Osamu Oikawa, Kazuyoshi Okada.   

Abstract

Cholesterol crystal embolism (CCE) is an arterio-arterial embolism originating from the breakdown of atherosclerotic plaques in the aortic wall. The embolism affects the skin and kidney particularly, as well as frequently affects the gastrointestinal tract and other organs. Although there are no clearly effective direct therapies for CCE, corticosteroid therapy and combination therapy with low-density lipoprotein apheresis (LDL-A) followed by corticosteroids were recently reported to be effective for renal manifestations in some cases. However, few cases offer suggestions for the treatment of skin lesions caused by CCE. We report here a case of a 58-year-old man diagnosed with CCE with skin manifestations and kidney dysfunction who achieved complete remission after LDL-A. LDL-A may be a useful treatment for CCE, particularly in cases with skin manifestations.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25821197     DOI: 10.1007/s10047-015-0830-4

Source DB:  PubMed          Journal:  J Artif Organs        ISSN: 1434-7229            Impact factor:   1.731


  9 in total

1.  [A case of suspected cholesterol embolism].

Authors:  Kiyotaka Sato; Hiroaki Shimizu; Masato Kato
Journal:  Masui       Date:  2002-02

2.  Low-density lipoprotein apheresis ameliorates monthly estimated glomerular filtration rate declines in patients with renal cholesterol crystal embolism.

Authors:  Keiji Hirai; Susumu Ookawara; Haruhisa Miyazawa; Kiyonori Ito; Yuichirou Ueda; Yoshio Kaku; Taro Hoshino; Izumi Yoshida; Kaoru Tabei
Journal:  J Artif Organs       Date:  2014-11-04       Impact factor: 1.731

3.  Atheroembolism in cardiac surgery.

Authors:  John R Doty; Robb E Wilentz; Jorge D Salazar; Ralph H Hruban; Duke E Cameron
Journal:  Ann Thorac Surg       Date:  2003-04       Impact factor: 4.330

4.  Low-dose prednisolone ameliorates acute renal failure caused by cholesterol crystal embolism.

Authors:  M Nakayama; M Nagata; T Hirano; K Sugai; R Katafuchi; S Imayama; N Uesugi; T Tsuchihashi; H Kumagai
Journal:  Clin Nephrol       Date:  2006-10       Impact factor: 0.975

5.  Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans.

Authors:  O Tamai; H Matsuoka; H Itabe; Y Wada; K Kohno; T Imaizumi
Journal:  Circulation       Date:  1997-01-07       Impact factor: 29.690

6.  [Lethal cholesterol crystal embolization syndrome after operation for abdominal aortic aneurysm].

Authors:  Yuji Sekine; Tatsuya Furutake; Takayoshi Kusuhara; Kenta Ann; Daisuke Nakatsuka; Michihito Nonaka; Atsushi Iwakura; Kazuo Yamanaka
Journal:  Kyobu Geka       Date:  2011-03

7.  Renal cholesterol embolism: analysis of two spontaneous autopsy cases.

Authors:  Takashi Ehara; Masanobu Yazawa; Kounosuke Konishi; Kazuhiko Hora; Hidekazu Shigematsu
Journal:  Nephrology (Carlton)       Date:  2005-02       Impact factor: 2.506

8.  Chronic cholesterol crystal embolism with a spontaneous onset.

Authors:  Mio Enomae; Shin-ichi Takeda; Keiichi Yoshimoto; Kiyoshi Takagawa
Journal:  Intern Med       Date:  2007-07-17       Impact factor: 1.271

9.  Acute renal failure due to cholesterol crystal embolism treated with LDL apheresis followed by corticosteroid and candesartan.

Authors:  Kouichi Tamura; Masanari Umemura; Hideto Yano; Masashi Sakai; Yoko Sakurai; Yuko Tsurumi; Yuichi Koide; Takashi Usui; Machiko Yabana; Yoshiyuki Toya; Yasuo Tokita; Satoshi Umemura
Journal:  Clin Exp Nephrol       Date:  2003-03       Impact factor: 2.801

  9 in total
  3 in total

1.  Efficacy of low-density lipoprotein apheresis combined with corticosteroids for cholesterol crystal embolism.

Authors:  Katsuya Ishiyama; Toshinobu Sato; Takuhiro Yamaguchi; Yoshio Taguma
Journal:  Clin Exp Nephrol       Date:  2016-04-21       Impact factor: 2.801

2.  Clinical study of blood purification therapy in critical care in Japan: results from the survey research of the Japan Society for Blood Purification in Critical Care in 2013.

Authors:  Toshiaki Arimura; Masanori Abe; Hidetoshi Shiga; Hiroshi Katayama; Kazo Kaizu; Shigeto Oda
Journal:  J Artif Organs       Date:  2017-06-09       Impact factor: 1.731

3.  An Autopsy Case of Acute Pancreatitis Caused by Cholesterol Crystal Embolization.

Authors:  Yuto Sato; Kazuhisa Okamoto; Masahide Fukuda; Yuzo Oyama; Yoshihiko Kondo; Haruto Nishida; Tsutomu Daa; Kazumi Togo; Akira Sonoda; Kensuke Fukuda; Osamu Matsunari; Ryo Ogawa; Koichi Honda; Kazuhiro Mizukami; Tadayoshi Okimoto; Masaaki Kodama; Kazunari Murakami
Journal:  Intern Med       Date:  2020-10-14       Impact factor: 1.271

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.